Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hu Lei

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Cell Death & Disease|September 15, 2017
Identification of 11(13)-dehydroivaxillin as a potent therapeutic agent against non-Hodgkin's lymphomaXinhua Xiao, Huiliang Li, Huizi Jin, et al.
Signal Transduction and Targeted Therapy|October 30, 2018
USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemiaHuizhuang Shan, Xiangyun Li, Xinhua Xiao, et al.
Molecular Medicine Reports|January 20, 2016
Targeting peroxiredoxin I potentiates 1,25-dihydroxyvitamin D3-induced cell differentiation in leukemia cellsWei Wei, Chuanxu Liu, Dongjun Qin, et al.
Cell Death & Disease|May 24, 2018
Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibitionBo Jing, Jin Jin, Rufang Xiang, et al.
Marine Drugs|July 25, 2022
Rare Carbon-Bridged Citrinin Dimers from the Starfish-Derived Symbiotic Fungus <i>Penicillium</i> sp. GGF16-1-2Hao Fan, Zhi-Mian Shi, Yan-Hu Lei, et al.
Plos One|August 14, 2014
Targeting catalase but not peroxiredoxins enhances arsenic trioxide-induced apoptosis in K562 cellsLi-Li Song, Yao-Yao Tu, Li Xia, et al.
Plos One|July 3, 2015
Hsp90 Is a Novel Target Molecule of CDDO-Me in Inhibiting Proliferation of Ovarian Cancer CellsDong-Jun Qin, Cai-Xia Tang, Li Yang, et al.
Cancer Cell International|March 27, 2019
WP1130 reveals USP24 as a novel target in T-cell acute lymphoblastic leukemiaHao Luo, Bo Jing, Yu Xia, et al.
Journal of Proteome Research|July 17, 2014
Important role of SUMOylation of Spliceosome factors in prostate cancer cellsDonghua Wen, Zhijian Xu, Li Xia, et al.
Blood Advances|March 6, 2025
Targeting the RBM39-MEK5 axis synergizes with bortezomib to inhibit the malignant growth of multiple myelomaJia Liu, Zilu Zhang, Wenbin Xu, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Cell Death & Disease|September 15, 2017
Identification of 11(13)-dehydroivaxillin as a potent therapeutic agent against non-Hodgkin's lymphomaXinhua Xiao, Huiliang Li, Huizi Jin, et al.
Signal Transduction and Targeted Therapy|October 30, 2018
USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemiaHuizhuang Shan, Xiangyun Li, Xinhua Xiao, et al.
Molecular Medicine Reports|January 20, 2016
Targeting peroxiredoxin I potentiates 1,25-dihydroxyvitamin D3-induced cell differentiation in leukemia cellsWei Wei, Chuanxu Liu, Dongjun Qin, et al.
Cell Death & Disease|May 24, 2018
Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibitionBo Jing, Jin Jin, Rufang Xiang, et al.
Marine Drugs|July 25, 2022
Rare Carbon-Bridged Citrinin Dimers from the Starfish-Derived Symbiotic Fungus <i>Penicillium</i> sp. GGF16-1-2Hao Fan, Zhi-Mian Shi, Yan-Hu Lei, et al.
Plos One|August 14, 2014
Targeting catalase but not peroxiredoxins enhances arsenic trioxide-induced apoptosis in K562 cellsLi-Li Song, Yao-Yao Tu, Li Xia, et al.
Plos One|July 3, 2015
Hsp90 Is a Novel Target Molecule of CDDO-Me in Inhibiting Proliferation of Ovarian Cancer CellsDong-Jun Qin, Cai-Xia Tang, Li Yang, et al.
Cancer Cell International|March 27, 2019
WP1130 reveals USP24 as a novel target in T-cell acute lymphoblastic leukemiaHao Luo, Bo Jing, Yu Xia, et al.
Journal of Proteome Research|July 17, 2014
Important role of SUMOylation of Spliceosome factors in prostate cancer cellsDonghua Wen, Zhijian Xu, Li Xia, et al.
Blood Advances|March 6, 2025
Targeting the RBM39-MEK5 axis synergizes with bortezomib to inhibit the malignant growth of multiple myelomaJia Liu, Zilu Zhang, Wenbin Xu, et al.
Pageof 7